In NPC, previous studies demonstrate that IGF1R inhibition, such as through Linsitinib, blocks downstream Akt/ERK phosphorylation, suppresses proliferation, induces apoptosis, and significantly radiosensitizes tumors by reversing resistance. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.